IDEAYA Biosciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2016 | — | $-4.1M | $9.7M |
| Dec 2017 | — | $-15.7M | $6.0M |
| Mar 2018 | — | $-21.3M | — |
| Jun 2018 | — | $-28.0M | $24.9M |
| Sep 2018 | — | $-40.7M | $21.5M |
| Dec 2018 | — | $-48.9M | $20.5M |
| Mar 2019 | — | $-58.1M | $35.3M |
| Jun 2019 | — | $120.6M | $88.1M |
| Sep 2019 | — | $110.4M | $38.8M |
| Dec 2019 | — | $100.4M | $34.1M |
| Mar 2020 | — | $89.1M | $35.5M |
| Jun 2020 | — | $172.1M | $147.5M |
| Sep 2020 | — | $195.4M | $81.2M |
| Dec 2020 | — | $198.3M | $72.0M |
| Mar 2021 | — | $233.1M | $136.8M |
| Jun 2021 | — | $240.3M | $90.4M |
| Sep 2021 | — | $317.6M | $108.4M |
| Dec 2021 | — | $301.5M | $92.0M |
| Mar 2022 | — | $288.7M | $55.3M |
| Jun 2022 | — | $269.3M | $49.1M |
| Sep 2022 | — | $368.8M | $102.0M |
| Dec 2022 | — | $349.5M | $68.6M |
| Mar 2023 | — | $333.8M | $67.2M |
| Jun 2023 | — | $501.6M | $102.8M |
| Sep 2023 | — | $508.0M | $151.9M |
| Dec 2023 | — | $621.1M | $157.0M |
| Mar 2024 | — | $935.3M | $108.3M |
| Jun 2024 | — | $931.7M | $183.0M |
| Sep 2024 | — | $1.18B | $400.3M |
| Dec 2024 | — | $1.06B | $84.4M |
| Mar 2025 | — | $1.02B | $130.0M |
| Jun 2025 | — | $959.7M | $114.6M |
| Sep 2025 | — | $1.09B | $298.9M |
| Dec 2025 | — | $1.02B | $112.8M |
| Mar 2026 | — | $937.3M | $157.5M |
| Jun 2026 | — | $1.20B | $272.6M |